TMCnet News
Insys Therapeutics to Report Third Quarter 2016 ResultsPHOENIX, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced that the Company will release its financial results for the third quarter 2016 on Thursday, November 3, 2016, before the U.S. financial markets open. Following the release of the financial results, Dr. John N. Kapoor, President and Chief Executive Officer, Darryl S. Baker, Chief Financial Officer, and Santosh Vetticaden, MD, PhD, Senior Vice President and Chief Medical Officer, will host a conference call at 10:00 a.m. Eastern Time. Interested parties may participate in the conference call by dialing (844) 263-8304 (U.S.) or (213) 358-0958 (International), 5-10 minutes prior to the start of the call. A replay will be available shortly after the completion of the call for one week by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International) and entering conference cal ID number 9540411. A live audio webcast and archive of the call will also be available at www.insysrx.com. About Insys Therapeutics, Inc. Subsys® and SyndrosTM are trademarks of Insys Therapeutics, Inc.
Contact: Lisa M. Wilson President In-Site Communications, Inc. 212-452-2793 |